Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sorafenib (200mg) Tablet
Therapeutic Category
Oncology, Anticancer
Dosage Form
Tablet
Packaging Type
in a Bottle
Packaging
30 Tablets
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Soranife 200 Tablet contains Sorafenib 200mg, a targeted anticancer agent used in the management of advanced liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and thyroid cancer. It helps in controlling cancer progression and improving treatment outcomes.
Sorafenib works by inhibiting multiple protein kinases involved in tumor cell growth and abnormal blood vessel formation. By blocking these pathways, it helps in slowing tumor proliferation and reducing cancer spread.
This medicine is commonly prescribed in advanced or metastatic cancer cases, where targeted therapy is required as part of long-term oncology treatment. Its oral dosage form supports convenient administration and better patient compliance.
For PCD pharma franchise partners, Soranife 200 Tablet is a high-value oncology product, available at best price for PCD pharma franchise. Its strong clinical demand, specialist prescription base, and consistent market requirement make it a strategic addition to any cancer care portfolio.
Common side effects may include fatigue, diarrhea, rash, hand-foot skin reaction, nausea, and hypertension. Rare but serious side effects include liver toxicity, severe bleeding, cardiac events, or severe allergic reactions. Patients should report any severe or persistent symptoms to their doctor immediately.
Soranife 200 Tablet is indicated for the treatment of advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and certain thyroid cancers, as prescribed by a healthcare professional.
Soranife 200 Tablet should be taken exactly as prescribed, usually on an empty stomach, and under strict medical supervision. Regular monitoring of liver function, blood pressure, and overall health is essential. Inform the doctor of any existing heart, liver, or kidney problems and all medications being taken to avoid interactions.
Store Soranife 200 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Sorafenib 200mg Tablet has significant demand in the oncology, hospital care, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer care and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from demand for cancer management under specialist medical supervision. Sorafenib 200mg is a targeted anticancer medication classified as a multikinase inhibitor Commonly prescribed for the treatment of hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and certain thyroid cancers as advised by oncologists Helps inhibit tumor cell growth and the development of blood vessels that supply tumors Frequently used as part of comprehensive oncology treatment plans requiring specialist monitoring Convenient oral tablet formulation supports outpatient cancer care when prescribed by healthcare professionals Widely prescribed by oncologists, hemato-oncologists, and cancer care specialists This strengthens a comprehensive oncology and specialty care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sorafenib 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from specialty healthcare demand, hospital procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the oncology segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.